Suppr超能文献

2型糖尿病患者蛋白尿轨迹的临床特征及意义:弗里曼特尔糖尿病研究第2阶段

Clinical Features and Implications of Albuminuria Trajectories in Type 2 Diabetes: The Fremantle Diabetes Study Phase 2.

作者信息

Davis Wendy A, Chakera Aron, Chubb S A Paul, Davis Timothy M E

机构信息

Medical School, University of Western Australia, Fremantle Hospital, Fremantle, WA 6160, Australia.

Harry Perkins Institute for Medical Research, University of Western Australia, Crawley, WA 6009, Australia.

出版信息

J Endocr Soc. 2025 Apr 8;9(6):bvaf062. doi: 10.1210/jendso/bvaf062. eCollection 2025 Jun.

Abstract

CONTEXT

The urinary albumin:creatinine ratio (uACR) can exhibit significant temporal changes but few studies have characterized transition patterns between uACR categories in type 2 diabetes.

OBJECTIVE

The study aim was to use group-based trajectory modeling (GBTM) to identify clusters of people with type 2 diabetes and distinct uACR trajectories.

METHODS

Of 1482 participants in the observational Fremantle Diabetes Study Phase 2, a total of 1145 (77.3%; mean age 65.4 years, 53.3% males) with 2 or more biennial uACR measurements over 6 years were included in GBTM. Independent baseline associates of uACR trajectory group membership were assessed using multinomial regression. Associations between group membership and changes in estimated glomerular filtration rate over 4 years were explored.

RESULTS

The optimum GBTM model comprised 6 categories: normoalbuminuria (n = 429, 37.5%), regression (n = 82, 7.2%), progression (n = 71, 6.2%), progression/regression (n = 104, 9.1%), persistent microalbuminuria (n = 401, 35.0%), and persistent macroalbuminuria (n = 58, 5.1%). The latter 5 groups had worse glycemic control than the normoalbuminuria group. The 3 groups starting from/returning to normoalbuminuria had heterogeneous baseline characteristics but a decline in renal function that was similar to the normoalbuminuric group. The persistent microalbuminuria group had adverse baseline cardiometabolic features and longitudinal renal outcomes relative to the normoalbuminuria/other microalbuminuria groups. The persistent macroalbuminuria group had, consistent with its baseline characteristics, the highest mortality (31.0% vs ≤18.5% in the other groups) and most rapid progression of renal dysfunction.

CONCLUSION

GBTM identified distinct uACR trajectory groups with clinical and prognostic implications, and could be used to stratify participants in clinical trials of new therapies for diabetic kidney disease.

摘要

背景

尿白蛋白与肌酐比值(uACR)可呈现显著的时间变化,但很少有研究描述2型糖尿病患者uACR类别之间的转变模式。

目的

本研究旨在使用基于群体的轨迹模型(GBTM)来识别2型糖尿病患者群体以及不同的uACR轨迹。

方法

在弗里曼特尔糖尿病观察性研究的1482名参与者中,共有1145名(77.3%;平均年龄65.4岁,53.3%为男性)在6年期间有2次或更多次的两年期uACR测量值被纳入GBTM分析。使用多项回归评估uACR轨迹组成员的独立基线关联因素。探讨了轨迹组成员与4年内估计肾小球滤过率变化之间的关联。

结果

最佳GBTM模型包括6个类别:正常白蛋白尿(n = 429,37.5%)、回归(n = 82,7.2%)、进展(n = 71,6.2%)、进展/回归(n = 104,9.1%)、持续性微量白蛋白尿(n = 401,35.0%)和持续性大量白蛋白尿(n = 58,5.1%)。后5组的血糖控制情况比正常白蛋白尿组差。从正常白蛋白尿开始/恢复到正常白蛋白尿的3组具有异质性的基线特征,但肾功能下降情况与正常白蛋白尿组相似。与正常白蛋白尿/其他微量白蛋白尿组相比,持续性微量白蛋白尿组具有不良的基线心脏代谢特征和纵向肾脏结局。持续性大量白蛋白尿组与其基线特征一致,死亡率最高(31.0%,而其他组≤18.5%),肾功能障碍进展最快。

结论

GBTM识别出了具有临床和预后意义的不同uACR轨迹组,可用于在糖尿病肾病新疗法的临床试验中对参与者进行分层。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b027/12038159/67c7fc5959be/bvaf062f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验